2024-08-01 2025-07-31 false No description of principal activity Acting Office - Tax and Accounts 1.0 12087522 bus:FullAccounts 2024-08-01 2025-07-31 12087522 bus:Micro-entities 2024-08-01 2025-07-31 12087522 bus:AuditExempt-NoAccountantsReport 2024-08-01 2025-07-31 12087522 bus:SmallCompaniesRegimeForAccounts 2024-08-01 2025-07-31 12087522 bus:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 12087522 2024-08-01 2025-07-31 12087522 2025-07-31 12087522 bus:RegisteredOffice 2024-08-01 2025-07-31 12087522 core:WithinOneYear 2025-07-31 12087522 core:AfterOneYear 2025-07-31 12087522 2023-08-01 12087522 bus:Director1 2024-08-01 2025-07-31 12087522 bus:Director1 2025-07-31 12087522 bus:Director1 2023-08-01 2024-07-31 12087522 bus:CompanySecretary1 2024-08-01 2025-07-31 12087522 bus:LeadAgentIfApplicable 2024-08-01 2025-07-31 12087522 2023-08-01 2024-07-31 12087522 2024-07-31 12087522 core:WithinOneYear 2024-07-31 12087522 core:AfterOneYear 2024-07-31 12087522 bus:EntityAccountantsOrAuditors 2023-08-01 2024-07-31 12087522 core:ComputerEquipment 2024-08-01 2025-07-31 12087522 core:ComputerEquipment 2025-07-31 12087522 core:ComputerEquipment 2024-07-31 12087522 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-07-31 12087522 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-07-31 12087522 core:CostValuation core:Non-currentFinancialInstruments 2025-07-31 12087522 core:CostValuation core:Non-currentFinancialInstruments 2024-07-31 12087522 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-07-31 12087522 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-07-31 12087522 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-07-31 12087522 core:ShareProfitOrLossIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-07-31 12087522 core:ProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2025-07-31 12087522 core:ImpairmentReversalProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2025-07-31 12087522 core:ForeignExchangeDifferencesIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-07-31 12087522 core:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-07-31 12087522 core:TransfersBetweenInvestmentClassesIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-07-31 12087522 core:Non-currentFinancialInstruments 2025-07-31 12087522 core:Non-currentFinancialInstruments 2024-07-31 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 12087522
England and Wales
Unaudited Financial Statements
for the year ended 31 July 2025
for
BIOFUSE CONSULTING LIMITED

BIOFUSE CONSULTING LIMITED ###### Statement of Financial Position As at 31 July 2025
|  | £ | 2025 £ |  | £ | 2024 £
--- | --- | --- | --- | --- | --- | ---
Fixed assets |  |  | 1,224 |  |  | 3,130
Current assets |  | 394,418 |  |  | 321,151 |
Creditors: amount falling due within one year |  | (45,045) |  |  | (54,041) |
Net current assets/(liabilities) |  |  | 349,373 |  |  | 267,110
Total assets less current liabilities |  |  | 350,597 |  |  | 270,240
Accruals and deferred income |  |  | (245) |  |  | (328)
Net assets/(liabilities) |  |  | 350,352 |  |  | 269,912
Capital and reserves |  |  | 350,352 |  |  | 269,912
For the year ended 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476 of the Companies Act 2006. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. The accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime. Signed on behalf of the board of directors:
--------------------------------------------- Stuart John Whiting Director |  |
Date approved: 22 April 2026 1

BIOFUSE CONSULTING LIMITED ###### Notes to the Accounts For the year ended 31 Jul 2025
Statutory Information Biofuse Consulting Limited is a private limited company, limited by shares, domiciled in England and Wales, registration number 12087522, registered office Apollo House, Hallam Way, Whitehills Business Park, Blackpool, FY4 5FS, United Kingdom. The presentation currency is £ sterling.
1. | Accounting Policies Basis of accounting The financial statements are prepared under the historical cost convention and in accordance with the FRS 105 Financial Reporting Standard for Micro Entities (effective January 2016).
2. | Average number of employees Average number of employees during the year was 1 (2024: 1).
3. | Director Advances Credits Note At 31 July 2025 the director owed £12,115.11 to Biofuse Consulting Limited. The loan is interest bearing, unsecured and has no set repayment terms.
2